{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:18:36Z","timestamp":1777526316267,"version":"3.51.4"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T00:00:00Z","timestamp":1354147200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001894","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T22:40:27Z","timestamp":1354228827000},"page":"e1894","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["A New Strategy Based on Smrho Protein Loaded Chitosan Nanoparticles as a Candidate Oral Vaccine against Schistosomiasis"],"prefix":"10.1371","volume":"6","author":[{"given":"Carolina R.","family":"Oliveira","sequence":"first","affiliation":[]},{"given":"C\u00edntia M. F.","family":"Rezende","sequence":"additional","affiliation":[]},{"given":"Marina R.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Ana Paula","family":"P\u00eago","sequence":"additional","affiliation":[]},{"given":"Olga","family":"Borges","sequence":"additional","affiliation":[]},{"given":"Alfredo M.","family":"Goes","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2012,11,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1056\/NEJMp0808041","article-title":"Toward the elimination of schistosomiasis","volume":"360","author":"CH King","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"ref2","unstructured":"WHO WHO (2010) <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs115\/en\/index.html\" xlink:type=\"simple\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs115\/en\/index.html<\/ext-link>. In: N\u00b0115 Fs, editor."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0001-706X(03)00029-9","article-title":"Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa","volume":"86","author":"MJ van der Werf","year":"2003","journal-title":"Acta Trop"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00436-001-0587-y","article-title":"Chemotherapeutic approaches to schistosomes: current knowledge and outlook","volume":"88","author":"A Harder","year":"2002","journal-title":"Parasitology Research"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0169-4758(97)01207-6","article-title":"Schistosomiasis vaccine: research to development","volume":"14","author":"NR Bergquist","year":"1998","journal-title":"Parasitology Today"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1471-4922(02)02301-2","article-title":"Schistosomiasis: from risk assessment to control","volume":"18","author":"N Bergquist","year":"2002","journal-title":"Trends in Parasitology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrmicro801","article-title":"Schistosomiasis","volume":"2","author":"L Chitsulo","year":"2004","journal-title":"Nature Review Microbiology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/CMR.00046-07","article-title":"Current status of vaccines for schistosomiasis","volume":"21","author":"DP McManus","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1017\/S003118209700173X","article-title":"Identification of Ras, MAP kinases, and a GAP protein in <italic>Schistosoma mansoni<\/italic> by immunoblotting and their putative involvement in male-female interaction","volume":"115","author":"P Sch\u00fcssler","year":"1997","journal-title":"Parasitology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0020-7519(03)00046-8","article-title":"Characterisation of a Rho homologue of <italic>Schistosoma mansoni<\/italic>","volume":"33","author":"JJ Vermeire","year":"2003","journal-title":"Int J Parasitol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","article-title":"Human schistosomiasis","volume":"368","author":"B Gryseels","year":"2006","journal-title":"The Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1517\/13543771003730425","article-title":"Recent advances in mucosal delivery of vaccines: role of mucoadhesive\/biodegradable polymeric carriers","volume":"20","author":"N Mishra","year":"2010","journal-title":"Expert Opin Ther Pat"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0264-410X(99)00195-4","article-title":"Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines","volume":"18","author":"I Jabbal-Gill","year":"1999","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/187221110791185015","article-title":"Mucosal delivery of vaccines: role of mucoadhesive\/biodegradable polymers","volume":"4","author":"N Garg","year":"2010","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"ref15","unstructured":"Borges OMF (2007) O uso de nanopart\u00edculas de quitosano, revestidas com alginato como adjuvante do antig\u00e9nio da hepatite B na vacina\u00e7\u00e3o atrav\u00e9s das mucosas oral e nasal. Coimbra - Portugal: Universidade de Coimbra."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.vaccine.2006.11.034","article-title":"Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination","volume":"25","author":"DA Zaharoff","year":"2007","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature05746","article-title":"Chitin induces accumulation in tissue of innate immune cells associated with allergy","volume":"447","author":"TA Reese","year":"2007","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1073\/pnas.1201042109","article-title":"Contribution of IL-33\u2013activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice","volume":"109","author":"K Yasuda","year":"2012","journal-title":"PNAS"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1189\/jlb.0904541","article-title":"Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration","volume":"78","author":"C Porporatto","year":"2005","journal-title":"J Leuk Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1128\/IAI.69.10.6123-6130.2001","article-title":"Th1 Adjuvant N-Acetyl-d-Glucosamine Polymer Up-Regulates Th1 Immunity but Down-Regulates Th2 Immunity against a Mycobacterial Protein (MPB-59) in Interleukin-10-Knockout and Wild-Type Mice","volume":"69","author":"Y Shibata","year":"2001","journal-title":"Infect Immun"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1211\/0022357011776441","article-title":"Chitosan: some pharmaceutical and biological aspects - an update","volume":"53","author":"AK Singla","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"ref22","first-page":"157","article-title":"The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line","volume":"13","author":"G Ranaldi","year":"2002","journal-title":"The Journal of Nutritional Biochemistry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0168-3659(00)00361-8","article-title":"Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency","volume":"70","author":"H Mao","year":"2001","journal-title":"J Control Release"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2005.04.037","article-title":"Preparation of coated nanoparticles for a new mucosal vaccine delivery system","volume":"299","author":"O Borges","year":"2005","journal-title":"Int J Pharm"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jconrel.2006.06.011","article-title":"Uptake studies in rat peyer&apos;s patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination","volume":"114","author":"O Borges","year":"2006","journal-title":"J Control Release"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"MR Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1016\/S0032-3861(00)00713-8","article-title":"An infrared investigation in relation with chitin and chitosan characterization","volume":"42","author":"J Brugnerotto","year":"2001","journal-title":"Polymer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jbm.b.10020","article-title":"Endotoxin contamination in wound dressings made of natural biomaterials","volume":"66B","author":"Y Nakagawa","year":"2003","journal-title":"Journal of biomedical materials research part B: Applied Biomaterials"},{"key":"ref29","unstructured":"USP (2005) United States Pharmacopeia,. General Chapter 85 - Bacterial Endotoxins Test"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.actbio.2009.04.021","article-title":"Improving chitosan-mediated gene transfer by the introduction of intracellular buffering moieties into the chitosan backbone","volume":"5","author":"C Moreira","year":"2009","journal-title":"Acta Biomater"},{"key":"ref31","first-page":"11","article-title":"Oral Vaccination Based on DNA-Chitosan Nanoparticles against <italic>Schistosoma mansoni<\/italic> Infection","volume":"2012","author":"C Oliveira","year":"2012","journal-title":"TSWJ"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11046-012-9530-2","article-title":"Protective effect of rPb40 as an adjuvant for chemotherapy in experimental paracoccidioidomycosis","volume":"174","author":"V Fernandes","year":"2012","journal-title":"Mycopathologia"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1017\/S0031182000086248","article-title":"The infection of laboratory hosts with cercariae of <italic>Schistosoma mansoni<\/italic> and the recovery of the adult worms","volume":"55","author":"SR Smithers","year":"1965","journal-title":"Parasitology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-3024.1989.tb00930.x","article-title":"Production and characterization of human monoclonal antibodies against Schistosoma mansoni","volume":"11","author":"AM Goes","year":"1989","journal-title":"Parasite Immunology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-5173(03)00408-3","article-title":"Ultrasonication of chitosan and chitosan nanoparticles","volume":"265","author":"ESK Tang","year":"2003","journal-title":"Int J Pharm"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1371\/journal.pntd.0000244","article-title":"Trick or Treat: The Role of Vaccines in Integrated Schistosomiasis Control","volume":"2","author":"R Bergquist","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1128\/IAI.72.10.5535-5547.2004","article-title":"Enteric Pathogens as Vaccine Vectors for Foreign Antigen Delivery","volume":"72","author":"CN Kotton","year":"2004","journal-title":"Infect Immun"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0142-9612(01)00391-X","article-title":"Blood protein adsorption onto chitosan","volume":"23","author":"J Benesch","year":"2002","journal-title":"Biomaterials"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1472-6750-8-89","article-title":"Preparation of alginate coated chitosan microparticles for vaccine delivery","volume":"8","author":"XY Li","year":"2008","journal-title":"BMC Biotechnol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1023\/B:PHAM.0000041443.17935.33","article-title":"Novel approaches to vaccine delivery","volume":"21","author":"DT O'Hagan","year":"2004","journal-title":"Pharm Res"},{"key":"ref41","first-page":"765","article-title":"Recent advances of chitosan nanoparticles as drug carriers","volume":"6","author":"J Wang","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1211\/jpp.58.8.0002","article-title":"Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery","volume":"58","author":"S Chopra","year":"2006","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/17425247.2.5.843","article-title":"The potential of chitosan for the oral administration of peptides","volume":"2","author":"C Prego","year":"2005","journal-title":"Expert Opinion on Drug Delivery"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0168-3659(01)00407-2","article-title":"Chitosan-based nanoparticles for topical genetic immunization","volume":"75","author":"Z Cui","year":"2001","journal-title":"J Control Release"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S0264-410X(02)00686-2","article-title":"Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice","volume":"21","author":"M Lubben","year":"2003","journal-title":"Vaccine"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1128\/JVI.71.4.2844-2850.1997","article-title":"Orally administered microencapsulated reovirus can bypass suckled, neutralizing maternal antibody that inhibits active immunization of neonates","volume":"71","author":"SB Periwal","year":"1997","journal-title":"J Virology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0168-3659(95)00155-7","article-title":"Oral vaccination with alginate microsphere systems","volume":"39","author":"TL Bowersock","year":"1996","journal-title":"J Control Release"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0008-6215(93)84094-M","article-title":"An influence of the structure of alginate on the chemotactic activity of macrophages and the antitumor activity","volume":"243","author":"M Fujihara","year":"1993","journal-title":"Carbohydrate Research"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejps.2011.05.015","article-title":"Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate","volume":"44","author":"E Mata","year":"2011","journal-title":"Eur J Pharm Sci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0952-7915(95)80095-6","article-title":"Cytokine regulation of granuloma formation in schistosomiasis","volume":"7","author":"TA Wynn","year":"1995","journal-title":"Curr Opin Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.4049\/jimmunol.180.6.3797","article-title":"Attenuating Regulatory T Cell Induction by TLR Agonists through Inhibition of p38 MAPK Signaling in Dendritic Cells Enhances Their Efficacy as Vaccine Adjuvants and Cancer Immunotherapeutics","volume":"180","author":"AG Jarnicki","year":"2008","journal-title":"The Journal of Immunology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2010.06.009","article-title":"Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination","volume":"148","author":"B Slutter","year":"2010","journal-title":"J Control Release"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/md8020292","article-title":"Chitins and Chitosans as Immunoadjuvants and Non-Allergenic Drug Carriers","volume":"8","author":"R Muzzarelli","year":"2010","journal-title":"Mar Drugs"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/sj.icb.7100014","article-title":"Immunopathology of schistosomiasis","volume":"85","author":"MS Wilson","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1749-6632.1996.tb52960.x","article-title":"Development of an Antipathology Vaccine for Schistosomiasis","volume":"797","author":"TA Wynn","year":"1996","journal-title":"Annals N Y Acad Sci"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"S Gordon","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1084\/jem.20052448","article-title":"Type 2 immunity is controlled by IL-4\/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system","volume":"203","author":"D Voehringer","year":"2006","journal-title":"The Journal of Experimental Medicine"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.4049\/jimmunol.181.6.4279","article-title":"TLR-2 and IL-17A in Chitin-Induced Macrophage Activation and Acute Inflammation","volume":"181","author":"CA Da Silva","year":"2008","journal-title":"J Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1074-7613(04)00107-4","article-title":"Alternative Macrophage Activation Is Essential for Survival during Schistosomiasis and Downmodulates T Helper 1 Responses and Immunopathology","volume":"20","author":"DBR Herbert","year":"2004","journal-title":"Immunity"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0169-4758(97)01198-8","article-title":"Why Don&apos;t We Have a Schistosomiasis Vaccine?","volume":"14","author":"RA Wilson","year":"1998","journal-title":"Parasitology Today"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T05:52:27Z","timestamp":1594965147000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001894"}},"subtitle":[],"editor":[{"given":"John Pius","family":"Dalton","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2012,11,29]]},"references-count":60,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001894","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,29]]}}}